bivalirudin

FDA Drug Profile — bivalirudin, Bivalirudin

bivalirudin is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand names including bivalirudin, Bivalirudin. Available dosage forms: injection, powder, lyophilized, for suspension, injection, powder, lyophilized, for solution, powder.

Drug details

Generic Name
bivalirudin
Brand Names
bivalirudin, Bivalirudin
Application Number
ANDA213078
Sponsor
Slate Run Pharmaceuticals, LLC
NDC Codes
10
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, POWDER
Routes
INTRAVENOUS
Active Ingredients
BIVALIRUDIN

Indications and Usage

1 INDICATIONS AND USAGE Bivalirudin for Injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Bivalirudin for Injection is a direct thrombin inhibitor indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia (HIT) or heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.